Geyer, Mark A.

Habituation revisited: An updated and revised description of the behavioral characteristics of habituation

Rankin, C. H., Abrams, T., Barry, R. J., Bhatnagar, S., Clayton, D. F., Colombo, J., Coppola, G., Geyer, M. A., Glanzman, D. L., Marsland, S., et al. (2009) · Neurobiology of Learning and Memory

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 1,665

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery

Schizophrenia research and treatmentDementia and Cognitive Impairment Research

Cited by 1,292

Serotonin research: contributions to understanding psychoses

GEYER, M., & VOLLENWEIDER, F. (2008) · Trends in Pharmacological Sciences

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 427

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology

Animal testing and alternativesNeuroscience and Neuropharmacology Research

Cited by 328

Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide

Swerdlow, N. R., Geyer, M. A., Vale, W. W., & Koob, G. F. (1986) · Psychopharmacology

Neuropeptides and Animal PhysiologyStress Responses and Cortisol

Cited by 299

Prepulse Inhibition Deficits and Perseverative Motor Patterns in Dopamine Transporter Knock-Out Mice: Differential Effects of D1 and D2 Receptor Antagonists

Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 271

Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach

Ogden, C. A., Rich, M. E., Schork, N. J., Paulus, M. P., Geyer, M. A., Lohr, J. B., Kuczenski, R., & Niculescu, A. B. (2004) · Molecular Psychiatry

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 221

Prepulse inhibition and genetic mouse models of schizophrenia

Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 218

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

Halberstadt, A. L., Koedood, L., Powell, S. B., & Geyer, M. A. (2011) · Journal of Psychopharmacology

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 213

Heart rate variability in bipolar mania and schizophrenia

Henry, B. L., Minassian, A., Paulus, M. P., Geyer, M. A., & Perry, W. (2010) · Journal of Psychiatric Research

Heart Rate Variability and Autonomic ControlBipolar Disorder and Treatment

Cited by 197

Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder

Ahmari, S. E., Risbrough, V. B., Geyer, M. A., & Simpson, H. B. (2012) · Neuropsychopharmacology

Obsessive-Compulsive Spectrum DisordersSchizophrenia research and treatment

Cited by 189

The Dopamine D2, but not D3or D4, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice

Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 174

The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?

Geyer, M. A. (2006) · Neurotoxicity Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 159

Prepulse inhibition deficits in patients with panic disorder

Ludewig, S., Ludewig, K., Geyer, M. A., Hell, D., & Vollenweider, F. X. (2002) · Depression and Anxiety

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSchizophrenia research and treatment

Cited by 157

Towards understanding the schizophrenia code: an expanded convergent functional genomics approach

Le‐Niculescu, H., Balaraman, Y., Patel, S., Tan, J., Sidhu, K., Jerome, R. E., Edenberg, H. J., Kuczenski, R., Geyer, M. A., Nurnberger, J. I., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 137

Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS

Green, M. F., Butler, P. D., Chen, Y., Geyer, M. A., Silverstein, S., Wynn, J. K., Yoon, J. H., & Zemon, V. (2009) · Schizophrenia Bulletin

Schizophrenia research and treatmentVisual perception and processing mechanisms

Cited by 113

Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice

Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 105

The Selective Serotonin-2A Receptor Antagonist M100907 Reverses Behavioral Deficits in Dopamine Transporter Knockout Mice

Barr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 103

Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice

Shanahan, N. A., Holick Pierz, K. A., Masten, V. L., Waeber, C., Ansorge, M., Gingrich, J. A., Geyer, M. A., Hen, R., & Dulawa, S. C. (2009) · Biological Psychiatry

Obsessive-Compulsive Spectrum DisordersNeurotransmitter Receptor Influence on Behavior

Cited by 102

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

Vollenweider, F. X., Remensberger, S., Hell, D., & Geyer, M. A. (1999) · Psychopharmacology

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 97

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Bespalov, A., Steckler, T., Altevogt, B., Koustova, E., Skolnick, P., Deaver, D., Millan, M. J., Bastlund, J. F., Doller, D., Witkin, J., et al. (2016) · Nature Reviews Drug Discovery

Animal testing and alternativesComputational Drug Discovery Methods

Cited by 84

Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats

Powell, S. B., Geyer, M. A., Preece, M. A., Pitcher, L. K., Reynolds, G. P., & Swerdlow, N. R. (2003) · Neuroscience

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 82

Isolation rearing effects on probabilistic learning and cognitive flexibility in rats

Amitai, N., Young, J. W., Higa, K., Sharp, R. F., Geyer, M. A., & Powell, S. B. (2014) · Cognitive, Affective, & Behavioral Neuroscience

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 74

Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test

Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 69